Forest Laboratories Names Karen L. Ling Senior Vice President, Chief Human Resources Officer

NEW YORK--()--Forest Laboratories, Inc. (NYSE:FRX) today announced that Karen Ling was appointed Senior Vice President and Chief Human Resources Officer. In this role, Ms. Ling will be responsible for leading the human resources organization, including talent management, leadership development, compensation & benefits, and staffing. Ms. Ling will report to Brent Saunders, Chief Executive Officer and President, and serve as a member of the Forest Executive Team upon joining the company on January 21, 2014. Ms. Ling succeeds Sally Paull, who joined Forest in 2009 and served as the company’s Senior Vice President of Human Resources.

Commenting on the appointment of Ms. Ling to this new position, Mr. Saunders said, “Karen brings to Forest extensive global human resources experience in pharmaceuticals and consumer health care. She is a strong business leader whose experience includes advising boards of directors on compensation and benefits-related matters, merger integration, and leading the human resources activities for commercial organizations with more than $40 billion in revenue and operations in more than 100 countries. As we continue to rejuvenate Forest, Ms. Ling’s skills and breadth of experience will be essential for Forest to retain, develop, and attract a best-in-class workforce capable of adapting to a changing environment.”

“I thank Sally for her outstanding service to Forest Laboratories. During her tenure, Sally transformed the human resources function, building its ability to support critical business strategies. Her leadership, global experience, and sound counsel to executive management strengthened all facets of the company’s talent infrastructure and created a strong platform for the Company’s next generation of growth,” said Mr. Saunders.

Ms. Ling most recently was Senior Vice President, Human Resources, for Merck & Co., Inc.’s Global Human Health and Consumer Care businesses worldwide. Prior to that role at Merck, she was Vice President, Compensation and Benefits. Prior to Merck, Ms. Ling was Group Vice President, Global Compensation & Benefits at Schering-Plough.

Ms. Ling spent 14 years at Wyeth in various positions of responsibility in human resources for the pharmaceutical, vaccines, and consumer health commercial businesses. She also worked in Wyeth Pharmaceutical’s Labor and Employment Department.

Prior to joining Wyeth, Ms. Ling practiced corporate law with Goldstein and Manello, P.C. in Boston.

Ms. Ling is a graduate of Yale University, with a degree in economics, and Boston University School of Law.

About Forest Laboratories and Its Products

Forest Laboratories (NYSE: FRX) is a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market. The Company markets a portfolio of branded drug products and develops new medicines to treat patients suffering from diseases principally in five therapeutic areas: central nervous system, cardiovascular, gastrointestinal, respiratory, and anti-infective. Our strategy of acquiring product rights for development and commercialization through licensing, collaborative partnerships and targeted mergers and acquisitions allows us to take advantage of attractive late-stage development and commercial opportunities, thereby managing the risks inherent in drug development. The Company is headquartered in New York, NY.

Contacts

Forest Laboratories, Inc.
INVESTORS:
Frank J. Murdolo, 1-212-224-6714
Vice President - Investor Relations
media.relations@frx.com
or
MEDIA:
Amanda Kaufman
Media Relations
amanda.kaufman@frx.com

Sharing

Contacts

Forest Laboratories, Inc.
INVESTORS:
Frank J. Murdolo, 1-212-224-6714
Vice President - Investor Relations
media.relations@frx.com
or
MEDIA:
Amanda Kaufman
Media Relations
amanda.kaufman@frx.com